Marty Mauser (Oscar Winner)🍸

What a terrible day to have eyes that can read

Love Dua and Radical optimism had some bops but the way Brat eats every single album here

Indulging in full blown nazi conspiracies in the replies too btw

@unholycyrusss Dual Lipa no question.

Who is the hottest pop star?

@PopMusic1977 @FearcyzD We need same song and individual ones

@FearcyzD Not in the same song though, right ?

Madonna x Lady Gaga will be on the official soundtrack of ‘The Devil Wears Prada 2’.

@jomwilli @_sn_n I'm talking to a friend, you disgusting SOB. Mind your own business. Your mom is prob a trailer trash whore going by your tweets and pfp

@ThirdWayLib @_sn_n Just like your mom, just not the election type.

me as a poll worker in a swing state after turning away 100 registered Republicans cause they lacked a passport

@beecuyazs @BarbiesAngel1 When did she say that? She said that about lemonade

@ThirdWayLib @BarbiesAngel1 the way adele herself said that sos should’ve won aoty at the grammys

Adele did it without 43 songs and 11 singles

@Ctrlfroot @samstein @Lauren_V_Egan Not more than ossoff but everyone else

NEW: In their frantic efforts to win back power, Democrats are warning up to something more... primal: Why not just run hotter candidates? These convos are really happening. And there is real science behind it. via @Lauren_V_Egan thebulwark.com/p/thirst-traps…

@BarbiesAngel1 Debatable. Neither the type I like

@ThirdWayLib And sza did it with a better album

@143ofashowboy Gracie Teenage dream Reputation

Eliminate one album from each row

Harper’s Bazaar explores the potential extinction of the “diva” in a new analysis, identifying Lady Gaga as perhaps the last great pop diva to rise before the social media era redefined stardom: “The Fame Monster represented Gaga’s transition from pop star to diva, like a beautiful butterfly emerging from a chrysalis wearing custom Alexander McQueen. She was a star you simply couldn’t look away from, with red carpet and stage looks that bridged the gap between fashion, performance and art. Gaga’s ascent to diva-dom coincided with the rise of social media, connecting the “new” and “old” worlds of celebrity. She was one of social media’s first “viral” musicians, but she also pursued more traditional markers of fame, saving her biggest stunts for the award shows, from faking her own death at the 2009 VMAs to showing up wearing a meat dress the following year. In that sense, Gaga was very last diva to be crowned in the pre-#Hashtag media landscape.”

@fanatic2026 @kellmanstreep Is OMITB new season confirmed for this year ?

Meryl is having a fantastic year

Martin Heinrich who endorsed Graham Platner is also voting for him

Fav song of all time The hook The bridge The Euro dance pop beats The music video The catchiness of the song Just pure pop perfection

@143ofashowboy The Fame Monster Blackout Teenage Dream 1989

Rank the pop bibles

@zachisalt Ugly retarded methhead thinks another ugly retard is electable

This is basically on the level of Hasan Piker endorsing Ivermectin for COVID during the early slop trial publication days. The claimed "working" treatment for Alzheimer's has an non-replicated and a biologically implausible effect size result that should call its trial into question. Specifically, the effect size in the ATHENEA trial (NeuroEPO plus) appears implausibly large when benchmarked against decades of Alzheimer's disease clinical trial data, particularly on the primary outcome: change in ADAS-Cog11 score at 48 weeks. Median ADAS-Cog11 change: -3.0 to -4.0 points (improvement) in the two active doses. Placebo: +4.0 points (worsening). Net treatment differences: 7.0 to 8.0 points This equates to treatment groups showing cognitive improvement while placebo worsened substantially, yielding an absolute benefit of ~7-8 points over 48 weeks. Not only is this far greater than the largest realistic effects in approved/symptomatic therapies (Donepezil, rivastigmine, galantamine: Peak benefits of 2–4 points vs. placebo, often at 6–12 months, then fading), it further shows an even more implausible reversal of disease. AD is relentlessly progressive; no neuroprotective agent (including EPO variants in other trials) has reversed cognitive scores. At best, one can hope for slowing or halting the disease. Improvement reported in this trial suggests reversal of deficits, and all in the face of discordant data. Hippocampal volumetry was neutral in the RCT: identical atrophy rates across active and placebo arms. Percentage change: ≈ −3.40% (0.5 mg dose), −3.26% (1.0 mg), −3.32% (placebo); p ≈ 0.98 (neutral across arms). This indicates no slowing of hippocampal atrophy despite the large cognitive benefits claimed. Cognitive reversal without any slowing of structural neurodegeneration is biologically discordant. AD cognition tracks closely with hippocampal loss. The authors speculated about “functional/synaptic” benefits to try and explain this, but this remains speculative and would require extraordinary evidence (synaptic density imaging, which wasn’t done). In other words: The brain continues to die, but the paper is reporting clinical reversal of disease. That is a huge red flag of discordance and should call the trial results into serious question. The manufacturer of this drug (Center of Molecular Immunology) designed, funded, analyzed, and authored both this trial and the follow-up study with even more far-reaching, less plausible results (this alone does not invalidate the results, but it should be noted in light of the implausible results). To date, this has never been replicated, and every published human clinical trial result (efficacy, safety, follow-up) on NeuroEPO/NeuralCIM in Alzheimer's is from Cuban research teams, sites, and sponsors (primarily CIM). If this is truly the Ivermectin-that-actually-works-miracle-story for Alzheimer's...great, I look forward to seeing the replication outside of Cuba. Until then, you should be skeptical, and you should definitely stop taking Hasan Piker seriously on medical treatments.

@HasanabiProd @charlescwcooke US already has Leqembi and Kinsula. There's also Aduhelm. Without Phase 3 results, regulatory authorities can't approve medication for a serious disease like Alzheimers. They're also working with a Canadian body, so if the treatment is approved Americans can absolutely access it

@charlescwcooke Research was published in 2023 and has been granted accelerated approval for treatment ever since.

Hasan Piker interviewed multiple Cuban doctors on the island today and found out they have a working treatment for Alzheimer’s. But because of the US Embargo, American citizens can’t even receive it. “We are killing our own citizens by refusing to allow American companies to even pay for Cuban medicine”

I'm sure an island state with annual income of $500 has found “cure” to Alzheimers

So this guy is so fucking stupid he can't even do a basic google search to look up Leqembi and Kinsula are already approved in the US and why the EU regulatory authorities haven't approved it. We live amongst truly retarded people with massive platforms